As the largest independent funder of MND/ALS research in Australia, FightMND’s vision is a world without MND. Integral in this vision is our determination to help facilitate the translation of the growing body of new knowledge about the disease into treatments and ultimately a cure for MND/ALS patients internationally. FightMND offers funding opportunities for both national and international researchers through a number of research schemes. Grant criteria and conditions are detailed below.

2022 RESEARCH GRANT SCHEMES

FightMND are pleased to announce two calls for proposals for the 2022 grant round.  Applications for the following FightMND Research Grants are open from November 1 2021.

  • Clinical Trial Grants
  • Drug Development Grants
  • IMPACT (IMProving and ACCelerating Translation) Grants

We are also pleased to announce a 3-year program focused on supporting capacity building, innovation and collaboration in MND research. Applications for the following FightMND Research Grants are open from December 31 2021.

  • Discovery Grants
  • Collaborative Initiatives Grants
  • Research Fellowships
    • Early-Career Fellowship
    • Bill Guest Mid-Career Fellowship

RESEARCH GRANT CRITERIA

Researchers working in areas relevant to improving the translation of/or progressing the development of potential therapies for Motor Neurone Disease (MND) are invited to apply for funding to support research projects commencing in 2022.

Clinical Trial Grants

These grants support Phase II/III clinical trials of novel, high-potential treatments for MND/ALS within the Australian Clinical Trials Consortium.

Click here to download a copy of :

These grants are awarded with an offer of up to AUD $1,500,000 (Phase II/III trial) with a project performance of up to 3 years.

Eligibility: Applications are open to MND/ALS researchers globally. Australian trial sites mandatory.

Drug Development Grants

These grants support the preclinical research, development and assessment of therapeutics for MND/ALS through to (and including) completion of Phase I clinical trials.

Click here to download a copy:

These grants are each awarded with an offer of up to AUD $1,000,000 in support available for 3-year projects (Projects with a period of performance of less than 3-years will also be considered).

Eligibility: Applications are open to MND/ALS researchers globally.

IMPACT Grants

IMPACT (IMProving and ACcelerating Translation) Grants support projects focused on one or more of the following key issues contributing to the lack of translation of effective treatments through to clinical trial for MND/ALS:

  1. Disease heterogeneity
  2. Lack of relevant preclinical models
  3. A lack of reliable disease biomarkers
  4. The challenge of drug delivery into the brain
  5. A lack of effective targeted gene therapies
  6. The untapped potential of stem cell therapy

Click here to download a copy of:

These grants are for support of 2-year projects up to the value of AUD $250,000. Proposals for both discovery and translational research stages will be considered. 

Eligibility: Applications are invited for research based in institutions within Australia. Investigators at all academic levels are eligible to submit applications.

Please note that applicants are limited to one (1) CIA and two (2) Co-CI applications, or three (3) Co-CI applications for this grant scheme.

Discovery Grants

These grants support novel, innovative projects seeking to discover and understand the cause/s of MND. Outcomes should provide significant advancements to the current understanding of MND.

Click here to download a copy:

These grants are each awarded with an offer of up to AUD $1,000,000 in support available for 3-year projects (Projects with a period of performance of less than 3-years will also be considered).

Eligibility: Applications are open to MND/ALS researchers globally. Primary investigators must be Australian residents.

Collaborative Initiatives Grants

These grants support of large-scale collaborative projects or programs aimed at helping to facilitate or directly supporting research into patient-focused initiatives aimed at gaining a better understanding of MND, or how to treat/prevent it.

Click here to download a copy:

These grants are each awarded with an offer of up to AUD $500,000 in support available for 1 – 3 year projects.

Eligibility: Applications are open to MND/ALS researchers globally. Primary investigators must be Australian residents.

FightMND Fellowships

FightMND are pleased to call for applications to support outstanding researchers in MND in both the early (0-5 years post-PhD) and mid-career (5-12 years post-PhD) categories.

Click here to download a copy:

Eligibility: Applications are open to MND/ALS researchers for research based in Institutions in Australia

KEY DATES

CLINICAL TRIAL AND DRUG DEVELOPMENT GRANTS

  • Applications Open: 01 November 2021
  • Letter of Intent due: 24 January 2022, at 18:00 AEDT
  • Submit Letter of Intent to: researchgrants@fightmnd.org.au
  • Invitation to submit full application: 04 February 2022
  • Full application due: 1 April 2022 at 18:00 AEDT
  • Recipients Notified: July 2022

IMPACT GRANTS AND EARLY CAREER FELLOWSHIPS

  • Applications Open: 01 November 2021
  • Notification of intention to submit due: 1 March 2022 at 18:00 AEDT
  • Full application due: 1 April 2022 at 18:00 AEDT
  • Recipients Notified: July 2022

DISCOVERY, COLLABORATIVE INITIATIVES GRANTS AND MID-CAREER FELLOWSHIPS

  • Applications Open: 31 December 2021
  • Notification of intention to submit due: 1 March 2022 at 18:00 AEDT
  • Full application due: 4 April 2022 at 18:00 AEST
  • Recipients Notified: July 2022